Table 1.
Indication | Population |
---|---|
JIA | Polyarticular rheumatoid factor positive/negative JIA (PJIA) |
Persistent or extended oligoarticular JIA (OJIA) | |
Enthesitis-related juvenile idiopathic arthritis and juvenile ankylosing spondylitis, including sacroiliitis (ERA) | |
Psoriatic juvenile idiopathic arthritis (PsA) | |
Systemic JIA (SJIA) | |
Uveitis | JIA-associated uveitis |
Non-infectious uveitis | |
Autoinflammatory Diseases | Familial Mediterranean Fever (FMF) |
TNF receptor-1 associated periodic syndrome (TRAPS) | |
Cryopyrin-associated periodic syndromes (CAPS) | |
Mevalonate Kinase Deficiency (MKD)/Hyperimmunoglobulin D syndrome (HIDS) | |
Unclassified periodic fever syndromes | |
Chronic recurrent multifocal osteomyelitis (CRMO) and Majeed syndrome | |
Deficiency of the interleukin-1 receptor antagonist (DIRA) | |
A20 haploinsufficiency (HA20) | |
Sideroblastic anemia with B cell immunodeficiency, periodic fevers and developmental delay syndrome (SIFD) | |
Pyogenic arthritis, pyoderma gangraenosum and acne (PAPA) | |
Deficiency of the interleukin-36 receptor antagonist (DITRA) | |
Palmar plantar pustulosis (PPP) | |
Pyoderma gangraenosum | |
Interferonopathy |
Chronic atypical neutrophilic dermatitis with lipodystrophy and elevated temperature (CANDLE) Stimulator of interferon genes-associated vasculopathy with onset in infancy (SAVI) |
Vasculitis | Takayasu arteritis |
Leucocytoclastic vasculitis | |
Granulomatosis with polyangiitis (GPA), Wegener’s Granulomatosis | |
Polyarteritis nodosa | |
Microscopic polyangiitis (MPA) | |
Eosinophilic granulomatosis with polyangiitis | |
Kawasaki Disease (KD) | |
Behcet disease | |
Connective Tissue Diseases | Systemic Lupus Erythematosus (SLE) |
Juvenile Dermatomyositis (JDM) | |
Paediatric sarcoidosis | |
Systemic and Localized Scleroderma | |
Sjögren Syndrome | |
Mixed connective tissue diseases (MCTD) | |
Macrophage activation syndrome | |
Psoriasis |